Literature DB >> 1595113

Small infarctions of cochlear, retinal, and encephalic tissue in young women.

J Schwitter1, R Agosti, P Ott, A Kalman, W Waespe.   

Abstract

BACKGROUND AND
PURPOSE: Recently, a rare syndrome that involves uniformly the brain, inner ear, and retina in previously healthy young women has been described. Brain biopsies and ophthalmologic examinations disclosed small infarcts as a pathoanatomical substrate of the disease. In previous reports, an autoimmune disorder or a coagulopathy have been suggested as possible etiologies. CASE DESCRIPTIONS: Both patients (aged 22 and 20 years) had brain involvement with neurological and neuropsychological deficits. Multifocal small hyperintensities were shown in magnetic resonance imaging of the brain. Findings of cerebrospinal fluid examination and electroencephalography were pathological in case 1 and of cerebral angiography in case 2. Both patients had a neurosensory hearing loss and multiple retinal branch arteriolar occlusions. Both women were on fenfluramine before onset of the disease. In case 1, attacks recurred during a follow-up of 34 months. At onset of the disease the 5-hydroxyindoleacetic acid and homovanillic acid levels of the cerebrospinal fluid were reduced; 13 months later the 5-hydroxyindoleacetic acid level was still reduced and the homovanillic acid level was low-normal. In case 2, with the longest follow-up of 13 years, the disease was active during only the initial 2 1/4 years. During this period a combination of oral anticoagulant and antiplatelet agents was ineffective.
CONCLUSIONS: Our findings could not support current etiologic hypotheses. Whether changes in 5-hydroxyindoleacetic acid and homovanillic acid levels in the cerebrospinal fluid and/or fenfluramine intake play a role in the pathogenesis of the disease remains to be elucidated.

Entities:  

Mesh:

Year:  1992        PMID: 1595113     DOI: 10.1161/01.str.23.6.903

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Encephalopathy, hearing loss and retinal occlusions (Susac's syndrome): a new case.

Authors:  M Maddestra; S Sabatini; A Paci
Journal:  Ital J Neurol Sci       Date:  1998-08

2.  Susac syndrome: report of four cases and review of the literature.

Authors:  Tai Hung Do; Christiane Fisch; François Evoy
Journal:  AJNR Am J Neuroradiol       Date:  2004-03       Impact factor: 3.825

3.  Treatment of Susac Syndrome.

Authors:  Ivana Vodopivec; Sashank Prasad
Journal:  Curr Treat Options Neurol       Date:  2016-01       Impact factor: 3.598

Review 4.  Characteristics of Susac syndrome: a review of all reported cases.

Authors:  Jan Dörr; Sarah Krautwald; Brigitte Wildemann; Sven Jarius; Marius Ringelstein; Thomas Duning; Orhan Aktas; Erich Bernd Ringelstein; Friedemann Paul; Ilka Kleffner
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

5.  Association of retinal vasculitis (Eales' disease) and Meniere-like vestibulocochlear symptoms.

Authors:  Wolfgang Wagner; Astrid Fehrmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-08-24       Impact factor: 2.503

6.  Susac syndrome in a young child.

Authors:  Thomas Jose Eluvathingal Muttikkal; Surjith Vattoth; Venugopal Naik Keluth Chavan
Journal:  Pediatr Radiol       Date:  2007-05-03

7.  Susac's Syndrome in a Patient Diagnosed with MS for 20 Years: A Case Report.

Authors:  Bijen Nazliel; Asli Akyol; Hale Zeynep Batur Caglayan; Irem Yildirim-Capraz; Ceyla Irkec
Journal:  Case Rep Neurol Med       Date:  2014-02-02

8.  Susac syndrome: clinical characteristics, clinical classification, and long-term prognosis.

Authors:  Vicktoria Vishnevskia-Dai; Joav Chapman; Roee Sheinfeld; Tal Sharon; Ruth Huna-Baron; Riri S Manor; Yehuda Shoenfeld; Ofira Zloto
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

9.  Susac's syndrome: first from India and youngest in the world.

Authors:  Gunjan Prakash; Shephali Jain; Mausam Gupta; Tirupat Nathi
Journal:  Indian J Ophthalmol       Date:  2013-12       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.